arrow
A

Ahmet Zehir

Memorial Sloan Kettering Cancer Center
H指数:82
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lexicon for Clonal Hematopoiesis in Liquid Biopsy

液体活检中克隆造血的词典

2025-12-260
OAAI
Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

作者更正:全基因组与转录组谱分析在儿童及年轻成人癌症中的可行性

2025-09-030
OAAI
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

种系遗传变异影响克隆造血景观和发展为恶性肿瘤

2025-07-150
OAAI
Leveraging RNA from DNA Extraction Lysate to Rescue “Insufficient” Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens

利用DNA提取裂解液中的RNA来挽救“不足”样本,以实现对肿瘤标本稀少患者更全面的基因组分析

2025-05-150
PRE
Age-related and organ-specific host mosaicism as a driver of dormant cancer cell awakening
2024-04-050
PRE
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

使用从指甲剪下的DNA对血液系统恶性肿瘤患者进行通用种系基因检测

2024-04-042
OAAI
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project (vol 32, pg 1626, 2021)
2024-01-010
OA
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

通过常规配对肿瘤和正常测序增强血液系统恶性肿瘤的临床评估

2023-10-2811
OAAI
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

量化癌症患者临床行动能力的扩展前景

2023-10-1754
OAAI
SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance

SPOT/Dx试点再分析和美国病理学家学院对KRAS和NRAS的能力测试证明了出色的实验室性能

2023-09-302
OA
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

循环肿瘤DNA指导治疗晚期非小细胞肺癌的总生存期

2022-11-1068
OA
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
2022-09-0129
OA